Site I on human albumin: Differences in the binding of (R)- and (S)-warfarin
โ Scribed by Carlo Bertucci; Alessandra Canepa; Giorgio A. Ascoli; Luis F. Lopes Guimaraes; Guy Felix
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 129 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0899-0042
No coin nor oath required. For personal study only.
โฆ Synopsis
The binding of drugs known to interact with area I on human serum albumin (HSA) was investigated using a chiral stationary phase obtained by anchoring HSA to a silica matrix. In particular, this high-pressure affinity chromatography selector was employed to study the binding properties of the individual enantiomers of warfarin. The pH and composition of the mobile phase modulate the enantioselective binding of warfarin. Displacement chromatography experiments evidenced significant differences in the binding of the warfarin enantiomers to site I. The (S)-enantiomer was shown to be a direct competitor for (R)-warfarin, while (R)-warfarin was an indirect competitor for the (S)-enantiomer. Salicylate directly competed with (R)-warfarin and indirectly with (S)warfarin. This behavior was confirmed by difference CD experiments, carried out with the same [HSA]/[drug] system in solution.
๐ SIMILAR VOLUMES
Receptors for polymerised human albumin are present on the pre-S sequence of the envelope protein of HBV and on the hepatocyte membrane and are thought to be involved in uptake of the virus by hepatocytes. Using a solid phase radioimmunoassay we demonstrate binding of HBsAg to polymerised human seru
The Cu(I1) binding site of human serum albumin is located on the N-terminal sequence Asp-Ala-His.l-4 It has been shown that the synthetic tripeptide Asp-Ala-His N-methylamide exhibits an affinity towards Cu(I1) ions even higher than that of serum albumin itself.5 In general, i t has been observed th